Literature DB >> 16962318

Expression of transcription factor Yin Yang 1 in human osteosarcomas.

Filomena de Nigris1, Chiara Botti, Anna de Chiara, Raffaele Rossiello, Gaetano Apice, Flavio Fazioli, Carmela Fiorito, Vincenzo Sica, Claudio Napoli.   

Abstract

The transcription factor Yin Yang 1 (YY1) is known to be present in some human cancer cell lines and its expression correlates with immune-mediated apoptosis. By using Western blot analysis, we have shown that the YY1 protein is strongly expressed in human osteosarcoma cells and localised mainly in the nucleus. Moreover, by using immunohistochemistry and RT-PCR techniques, we have analysed the expression of YY1 protein in biopsies from human osteosarcomas. The YY1 protein was not detectable by immunohistochemistry in osteoid tissue. However, its expression was restricted to osteosarcoma tissues. These data were confirmed by densitometric analysis of RT-PCR for YY1 expression. Thus, YY1 gene activation appears to be an early event in the process of osteoblastic transformation and its detection may represent, together with the analysis of other established markers, a useful diagnostic tool in human osteosarcomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962318     DOI: 10.1016/j.ejca.2006.06.008

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Different expression of CD146 in human normal and osteosarcoma cell lines.

Authors:  Concetta Schiano; Vincenzo Grimaldi; Amelia Casamassimi; Teresa Infante; Alessandra Esposito; Alfonso Giovane; Claudio Napoli
Journal:  Med Oncol       Date:  2012-01-21       Impact factor: 3.064

Review 2.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

Review 3.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

4.  Transcription regulator Yin-yang 1: from silence to cancer.

Authors:  Weidong Zhu; Samuel Y Olson; Hermes Garbán
Journal:  Crit Rev Oncog       Date:  2011

Review 5.  Neomorphic mutations create therapeutic challenges in cancer.

Authors:  V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

6.  YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.

Authors:  Guifen He; Qian Wang; Yuqi Zhou; Xiaohua Wu; Lan Wang; Nadire Duru; Xiangtao Kong; Pingzhao Zhang; Bo Wan; Long Sui; Qisang Guo; Jian-Jian Li; Long Yu
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

7.  Expression of YY1 in Differentiated Thyroid Cancer.

Authors:  Jéssica Arribas; Josep Castellví; Ricard Marcos; Carles Zafón; Antonia Velázquez
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

8.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

Review 9.  Receptor imaging of pediatric tumors: clinical practice and new developments.

Authors:  Heike E Daldrup-Link; Randall A Hawkins; Reinhard Meier; Robert E Goldsby; Dmitri Artemov
Journal:  Pediatr Radiol       Date:  2008-05-16

10.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.